Medicine and Dentistry
Hypoxic-Ischemic Encephalopathy
100%
Neonate
67%
Induced Hypothermia
56%
Brain Injury
48%
Injury
40%
Hypoxic Ischemic Encephalopathy
37%
Magnetic Resonance Imaging
31%
Brain Disease
30%
microRNA
29%
Vitamin D
21%
Gestational Age
21%
Hypotension
20%
Trisomy 18
19%
Stem Cell
19%
Hydrocortisone
19%
Trisomy 13
19%
Lung Dysplasia
19%
Ferroptosis
19%
Neonatal Intensive Care Unit
17%
Blood Pressure
17%
Neonatal Infant
17%
Pediatrics
15%
Childbirth
14%
Prematurity
14%
Stem Cell Therapy
14%
Pregnancy
14%
Drug Therapy
13%
Biological Marker
11%
Ischemic Injury
11%
Bayley Scales of Infant Development
11%
Prevalence
11%
Infection
11%
Infusion
10%
Bronchodilating Agent
10%
Cord Blood
10%
Antimicrobial Therapy
9%
Hyperbilirubinemia
9%
Nurse Practitioner
9%
Sterol Synthesis
9%
Guillain-Barré Syndrome
9%
Gastroesophageal Reflux
9%
Cross Sectional Study
9%
Encephalomalacia
9%
Tissue Injury
9%
Cholestasis
9%
Postpartum Depression
9%
Physiotherapist
9%
Shock (Circulatory)
9%
Social Determinants of Health
9%
Telehealth
9%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoxic Ischemic Encephalopathy
65%
Brain Injury
29%
Biological Marker
24%
Injury
24%
Hypotension
20%
microRNA
19%
Brain Disease
19%
Ferroptosis
19%
Lung Dysplasia
19%
Sterol
19%
Hydrocortisone
19%
Hypothermia
19%
Vitamin D
11%
Opiate
11%
Bronchodilating Agent
10%
Biocompatibility
9%
Inflammation
9%
Antimicrobial Therapy
9%
Drug Dependence
9%
Prematurity
9%
Ampicillin
9%
Mitochondrial DNA
9%
HIV-1 Transgenic Rat
9%
Acidemia
9%
Vaccination Policy
9%
Immunogenicity
9%
Shock
9%
Immunomodulation
9%
HIV
9%
Cancer Growth
9%
Infection
9%
Long Untranslated RNA
9%
Carboxylesterase
9%
Brain Hemorrhage
9%
Targeted Drug Delivery
9%
Tissue Injury
9%
7-Dehydrocholesterol
9%
Tubulin
9%
Cariprazine
8%
Disease
6%
Chlorpyrifos
5%
Adverse Outcome
5%
Mouse
5%
Keyphrases
Hypoxic-ischemic Encephalopathy
34%
Therapeutic Hypothermia
26%
Neonatal Encephalopathy
19%
Neonate
19%
Short-term Outcomes
19%
Hypoxic-ischemic Brain Injury
13%
Childrens
11%
Neonatal Hypoxic-ischemic Brain Injury
11%
Brain Injury
11%
Trisomy 18
9%
Adhesion
9%
Children's Hospitals Neonatal Consortium
9%
Cooling during Transport
9%
Passive Cooling
9%
Stem Cell Mobilization
9%
Direct Hyperbilirubinemia
9%
Extracellular Vesicles
9%
Physiological Potential
9%
Antimicrobial Therapy
9%
Late-onset Circulatory Collapse
9%
Maternal Postnatal Depression
9%
Biogenesis
9%
Body Imaging
9%
Ferroptosis
9%
Opioids
9%
Extremely Low Birth Weight Preterm Infant
9%
Opioid Exposure
9%
Substance Use Disorder
9%
Skin-to-skin
9%
Neonatal Brain MRI
9%
Chemical Inhibitors
9%
Physiological Function
9%
Inhaled Bronchodilators
9%
Paracrine Interactions
9%
Tissue Injury
9%
Stem Cell Proliferation
9%
Team Care
9%
Bronchopulmonary Dysplasia
9%
Toxicant Exposure
9%
Organophosphorus Toxicants
9%
Sterol Biosynthesis
9%
Miller Fisher Syndrome
9%
Cholesterol Metabolism
9%
7-ketocholesterol
9%
Therapy Utilization
9%
Stem Migration
9%
Surveillance Guidelines
9%
Stem Cells
9%
Hospitalised Infants
9%
Active-passive
9%